Table 2.
Hemodialysis treatment characteristics by age categories across DOPPS regions
| Hemodialysis treatment characteristics | Europe |
Australia and New Zealand |
Japan |
North America |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <45 years |
45 to 74 years |
≥75 years |
<45 years |
45 to 74 years |
≥75 years |
<45 years |
45 to 74 years |
≥75 years |
<45 years |
45 to 74 years |
≥75 years |
|||||||||||||
| mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | mean or % | 95% CI | |
| Vascular access (%) | ||||||||||||||||||||||||
| AV fistula | 78.5 | (73.9–83.1) | 71 | (68.8–73.2) | 68.5 | (65.2–71.7) | 75.5 | (63.7–87.2) | 76.8 | (72–81.6) | 80.5 | (72.7–88.3) | 93.1 | (88.8–97.3) | 93.5 | (92–95) | 91.4 | (88–94.7) | 55 | (48.7–61.4) | 46.3 | (43.2–49.4) | 44.2 | (39.4–49.1) |
| graft | 7.8 | (5.2–10.4) | 8.2 | (7–9.5) | 7.1 | (5.4–8.8) | 11.2 | (2.6–19.7) | 12.7 | (9–16.4) | 10.3 | (4.4–16.2) | 5.9 | (1.8–10) | 6 | (4.6–7.4) | 8.4 | (5.1–11.7) | 17.8 | (13.2–22.5) | 24.6 | (22–27.3) | 23.2 | (19.2–27.2) |
| permanent catheter | 12.2 | (8.4–16.1) | 19 | (17.1–21) | 23.1 | (20.2–26.1) | 11.3 | (2.7–20) | 9.5 | (6.1–12.8) | 6.9 | (1.9–11.8) | 0 | 0.3 | (0–0.8) | 0 | 25 | (19.5–30.5) | 27.6 | (24.7–30.5) | 31.8 | (27.1–36.5) | ||
| temporary catheter | 1.5 | (0–3.1) | 1.8 | (1.1–2.4) | 1.3 | (0.6–2) | 2 | (0–5.9) | 1 | (0–2.2) | 2.4 | (0–5.6) | 1 | (0–2.3) | 0.2 | (0–0.3) | 0.2 | (0–0.7) | 2.1 | (0.5–3.7) | 1.5 | (0.7–2.3) | 0.8 | (0–1.8) |
| Dialysis prescriptionsa (mean) | ||||||||||||||||||||||||
| treatment time (min) | 246 | (241–251) | 245 | (244–247) | 232 | (231–234) | 269 | (259–279) | 272 | (268–275) | 253 | (247–260) | 248 | (243–253) | 239 | (238–241) | 225 | (222–228) | 237 | (231–242) | 230 | (227–232) | 213 | (209–217) |
| treatment time (min/kg) | 3.8 | (3.7–4) | 3.6 | (3.5–3.6) | 3.6 | (3.6–3.7) | 3.8 | (3.4–4.1) | 3.7 | (3.6–3.8) | 3.8 | (3.6–4) | 4.4 | (4.3–4.6) | 4.6 | (4.5–4.6) | 4.8 | (4.7–4.9) | 3.2 | (3.1–3.4) | 3 | (3–3.1) | 3.3 | (3.2–3.4) |
| blood flow (ml/min) | 315 | (304–326) | 302 | (298–305) | 295 | (290–300) | 308 | (295–321) | 304 | (299–309) | 309 | (298–320) | 207 | (201–213) | 199 | (197–201) | 184 | (180–188) | 395 | (386–405) | 386 | (381–390) | 375 | (368–383) |
| ultrafiltration rate (ml/h) | 562 | (527–597) | 547 | (533–561) | 482 | (464–499) | 524 | (457–591) | 484 | (457–511) | 404 | (358–449) | 629 | (591–668) | 564 | (552–577) | 468 | (446–489) | 708 | (655–761) | 691 | (670–712) | 569 | (540–598) |
| Hypotension (%) | 5.5 | (1.8–9.2) | 3.7 | (2.8–4.6) | 2.3 | (1.2–3.4) | 2 | (0–6) | 1.9 | (0.4–3.4) | 0 | 3.6 | (0–7.9) | 3.9 | (2.7–5) | 3.4 | (1.1–5.8) | 1.6 | (0–3.5) | 2.3 | (1.2–3.4) | 1.4 | (0.4–2.4) | |
Cross section of hemodialysis patients in DOPPS III (2005 through 2007) (n = 8161). Bold numbers represent P < 0.05 compared to the elderly group (≥75 years) within each region.
a
Restricted to patients with three dialysis sessions per week (n = 7599). Europe includes United Kingdom, France, Germany, Italy, Spain, Belgium, and Sweden; North America includes United States and Canada. Abbreviation: AV, arteriovenous.